SCHEMBL6960397

SCHEMBL6960397

C#Cc1cc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)ccc1-c1ccco1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.57
PTGS1 P23219 9/20 0.57
PDPK1 O15530 7/20 0.57
CYP2C9 P11712 2/20 0.57
PTGES O14684 1/20 0.57
HDAC3 O15379 1/20 0.57
CA12 O43570 1/20 0.57
PDE5A O76074 1/20 0.57
ABCB11 O95342 1/20 0.57
MT-CO2 P00403 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
LMNA P02545 1/20 0.57
CA3 P07451 1/20 0.57
CYP3A4 P08684 1/20 0.57
ALOX5 P09917 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CYP2D6 P10635 1/20 0.57
ADRB3 P13945 1/20 0.57
ALOX15 P16050 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959494 0.91 PTGS2 (0.58) PTGS2PTGS1CYP2C9
SCHEMBL6956725 0.88
SCHEMBL6516750 0.87 PTGS2 (0.62) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6514563 0.86 PTGS2 (0.70) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6516811 0.86 PTGS2 (0.66) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6514494 0.85 PDPK1 (0.72) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6511692 0.84 PTGS2 (0.71) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6343163 0.82 PTGS2 (0.67) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6516212 0.81 PTGS2 (0.66) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL6948725 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1104758-B1 Acetylene derivatives as anti-inflammatory/analgesic agents PFIZER PROD INC (US) 2003-07-23 EP disclosed
US-6506779-B1 useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock. PFIZER INC. 2003-01-14 US disclosed
EP-1104758-A1 Acetylene derivatives as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2001-06-06 EP disclosed